NEUROCRINE BIOSCIENCES INC (NBIX) Stock Analyst Earnings Estimates
NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.489B 31.34% | 1.887B 26.76% | 2.355B 24.81% | 2.739B 16.29% | 3.202B 16.90% | 3.652B 14.05% | 4.305B 17.88% | 4.525B 5.11% | 4.825B 6.63% | 5.24B 8.60% | 5.818B 11.03% | |
| EBITDA YoY % growth | 266.3M 21.76% | 416.1M 56.25% | 610.1M 46.62% | 830.67M 36.15% | 1.147B 38.08% | 1.386B 20.84% | 1.842B 32.90% | 2.287B 24.16% | 2.694B 17.80% | N/A | N/A | |
| EBIT YoY % growth | 250.7M 20.64% | 394.8M 57.48% | 583M 47.67% | 554.48M -4.89% | 881.13M 58.91% | 1.145B 29.95% | 1.89B 65.07% | 1.966B 4.02% | 2.021B 2.80% | 2.504B 23.90% | 3.434B 37.14% | |
| Operating Margin | 16.84% | 20.92% | 24.75% | 20.24% | 27.52% | 31.35% | 43.90% | 43.45% | 41.89% | 47.79% | 59.02% | |
| EPS YoY % growth | 1.53 15.91% | 2.42 58.17% | 3.29 35.95% | 4.46 35.66% | 6.63 48.63% | 9.19 38.54% | 17.19 87.07% | 18.50 7.62% | 20.39 10.20% | 21.72 6.55% | 23.33 7.40% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 123.72% | 1.03 64.09% | 1.18 -4.75% | 1.25 24.94% | 2.38 153.47% | 2.61 152.60% | 2.72 130.14% | 2.71 116.74% |
| Revenue Q2Q % growth | 623.12M 20.92% | 669.15M 13.38% | 705.12M 13.35% | 736.59M 17.35% | 837.09M 34.34% | 876.87M 31.04% | 901.19M 27.81% | 934.44M 26.86% |
| EBITDA Q2Q % growth | 160.27M 43.74% | 167.41M 3.72% | 162.52M -20.64% | 170.14M -1.14% | 421.08M 162.73% | 441.13M 163.50% | 449.09M 176.33% | 466.2M 174.01% |
| EBIT Q2Q % growth | 109.01M 3.52% | 130.38M -11.85% | 149.81M -18.93% | 158.28M 9.16% | 421.08M 286.28% | 441.13M 238.34% | 449.09M 199.77% | 466.2M 194.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.00 -30.56% | 1.59 | -0.59 | -37.18% |
| Q3 2024 Q2Q % growth | 1.24 51.22% | 1.50 | -0.26 | -17.35% |
| Q2 2024 Q2Q % growth | 0.63 -33.68% | 1.08 | -0.45 | -41.42% |
| Q1 2024 Q2Q % growth | 0.42 153.16% | 1.03 | -0.61 | -59.17% |
| Q4 2023 Q2Q % growth | 1.44 63.64% | 1.17 | 0.27 | 23.28% |
| Q3 2023 Q2Q % growth | 0.82 18.84% | 0.99 | -0.17 | -16.79% |
| Q2 2023 Q2Q % growth | 0.95 627.78% | 0.79 | 0.16 | 19.84% |
| Q1 2023 Q2Q % growth | -0.79 -664.29% | 0.13 | -0.92 | -697.25% |
| Q4 2022 Q2Q % growth | 0.88 1,200.00% | 1.18 | -0.30 | -25.33% |
| Q3 2022 Q2Q % growth | 0.69 7.81% | 0.81 | -0.12 | -14.90% |
| Q2 2022 Q2Q % growth | -0.18 -141.86% | 0.61 | -0.79 | -129.58% |
| Q1 2022 Q2Q % growth | 0.14 -57.58% | 0.36 | -0.22 | -60.95% |
| Q4 2021 Q2Q % growth | -0.08 -111.11% | 0.53 | -0.61 | -115.18% |
| Q3 2021 Q2Q % growth | 0.64 203.23% | 0.62 | 0.02 | 3.97% |
| Q2 2021 Q2Q % growth | 0.43 -46.91% | 0.49 | -0.06 | -12.38% |
| Q1 2021 Q2Q % growth | 0.33 -15.38% | 0.52 | -0.19 | -36.84% |
| Q4 2020 Q2Q % growth | 0.72 105.71% | 0.55 | 0.17 | 31.63% |
| Q3 2020 Q2Q % growth | -0.62 -210.71% | 0.17 | -0.79 | -456.57% |
| Q2 2020 Q2Q % growth | 0.81 50.00% | 0.75 | 0.06 | 8.08% |
| Q1 2020 Q2Q % growth | 0.39 134.82% | 0.55 | -0.16 | -29.31% |
| Q4 2019 Q2Q % growth | 0.35 | 0.77 | -0.42 | -54.31% |
| Q3 2019 Q2Q % growth | 0.56 | 0.65 | -0.09 | -13.98% |
| Q2 2019 Q2Q % growth | 0.54 | 0.11 | 0.43 | 396.12% |
| Q1 2019 Q2Q % growth | -1.12 | -0.94 | -0.18 | -18.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 627.7M 21.84% | 641.57M | -13.87M | -2.16% |
| Q3 2024 Q2Q % growth | 622.1M 24.72% | 612.64M | 9.46M | 1.54% |
| Q2 2024 Q2Q % growth | 590.2M 30.37% | 556.86M | 33.34M | 5.99% |
| Q1 2024 Q2Q % growth | 515.3M 22.57% | 522.21M | -6.91M | -1.32% |
| Q4 2023 Q2Q % growth | 515.2M 25.05% | 528.84M | -13.64M | -2.58% |
| Q3 2023 Q2Q % growth | 498.8M 28.59% | 479.9M | 18.9M | 3.94% |
| Q2 2023 Q2Q % growth | 452.7M 19.70% | 456.25M | -3.55M | -0.78% |
| Q1 2023 Q2Q % growth | 420.4M 35.35% | 417.45M | 2.95M | 0.71% |
| Q4 2022 Q2Q % growth | 412M 32.05% | 417.05M | -5.05M | -1.21% |
| Q3 2022 Q2Q % growth | 387.9M 31.05% | 384.51M | 3.39M | 0.88% |
| Q2 2022 Q2Q % growth | 378.2M 30.91% | 348.13M | 30.07M | 8.64% |
| Q1 2022 Q2Q % growth | 310.6M 31.28% | 310.27M | 330K | 0.11% |
| Q4 2021 Q2Q % growth | 312M 25.86% | 323.85M | -11.85M | -3.66% |
| Q3 2021 Q2Q % growth | 296M 14.51% | 303.75M | -7.75M | -2.55% |
| Q2 2021 Q2Q % growth | 288.9M -4.46% | 279M | 9.9M | 3.55% |
| Q1 2021 Q2Q % growth | 236.6M -0.21% | 255.65M | -19.05M | -7.45% |
| Q4 2020 Q2Q % growth | 247.9M 1.60% | 266.32M | -18.42M | -6.92% |
| Q3 2020 Q2Q % growth | 258.5M 16.39% | 288.7M | -30.2M | -10.46% |
| Q2 2020 Q2Q % growth | 302.4M 64.71% | 265.73M | 36.67M | 13.80% |
| Q1 2020 Q2Q % growth | 237.1M 71.32% | 228.35M | 8.75M | 3.83% |
| Q4 2019 Q2Q % growth | 244M | 235.56M | 8.44M | 3.58% |
| Q3 2019 Q2Q % growth | 222.1M | 215.86M | 6.24M | 2.89% |
| Q2 2019 Q2Q % growth | 183.6M | 165.19M | 18.41M | 11.14% |
| Q1 2019 Q2Q % growth | 138.4M | 139.77M | -1.37M | -0.98% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -30.56% | -10.78% | -28.16% | -28.89% |
| Revenue | -2.13% | 9.29% | -3.22% | -2.04% |